Physical activity releases prostate-specific antigen (PSA) from the prostate gland into blood and increases serum PSA concentrations

Clinical Chemistry

Volumn 42, Issue 5, 1996, Pages 691-695

  Oremek, Gerhard M ^a   Seiffert, Ulrich B ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

exercise, effects of; prostate cancer; prostatic acid phosphatase

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETRY; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; EXERCISE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHYSICAL ACTIVITY; PROSTATE CANCER; PROSTATE EPITHELIUM;

EID: 0030001967     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.5.691     Document Type: Article

References (25)

1. Humphrey PA, Baty J, Keetch D. Relationship between serum prostate specific antigen, needle biopsy findings, and histopathologic features of prostatic carcinoma in radical prostatectomy tissues. Cancer 1995;75(Suppl):1842-9.
2. Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update 1994. J Urol 1994;152:1358-68.
3. Benson MC. Prostate specific antigen [Editorial]. J Urol 1994;152: 2046-8.
4. Diamandis EP. New diagnostic applications and physiological functions of prostatic specific antigen. Scand J Clin Lab Invest 1995;55(Suppl 221):105-12.
5. Diamandis EP, Yu H. New biological functions of prostate-specific antigen [Editorial]? J Clin Endocrinol Metab 1995;80:1515-7.
6. Peehl DM. Prostate specific antigen role and function. Cancer 1995;75(Suppl):2021-6.
7. Graves HCB. Nonprostatic sources of prostate-specific antigen: a hormone-dependent phenomenon [Editorial]? Clin Chem 1995; 41:7-9.
8. Chybowski FM, Bergstralh EJ, Oesterling JE. The effect of digital rectal examination on the serum prostate specific antigen concentration: results of a randomized study. J Urol 1992;148:83-6.
9. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909-16.
10. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate [Review]. J Urol 1991;145:907-23.
11. Simak R, Madersbacher S, Zhang ZF, Maier U. The impact of ejaculation on serum prostate specific antigen. J Urol 1993;150: 895-7.
12. Kirkali Z, Kirkali G, Esen A. Effect of ejaculation on prostate specific antigen levels in normal men. Eur Urol 1995;27:292-4.
13. Leventhal EK, Rosanski TA, Morey AF, Rholl V. The effects of exercise and activity on serum prostate specific antigen levels. J Urol 1993;150:893-4.
14. Stamey TA, Prestigiacomo AF, Chen Z. Standardization of immunoassays for prostate specific antigen. A different view based on experimental observations. Cancer 1994;74:1662-4.
15. Bruce RA, Blackmon JR, Jones JW, Strait G. Exercising testing in adult normal subjects and cardiac patients. Pediatrics 1963; 32(Suppl II):742-56.
16. Oesterling JE. Prostate specific antigen: its role in the diagnosis and staging of prostate cancer. Cancer 1995;75:1795-804.
17. Lepor H, Wang B, Shapiro E. Relationship between prostatic epithelial volume and serum prostate specific antigen levels. Urology 1994;44:199-205.
18. Clements R, Etherington RJ, Griffiths GJ, Peeling WB, Hughes H, Penney MD. Inter-relation between measurement of serum prostatic specific antigen and transrectal ultrasound in the diagnosis of benign prostatic hyperplasia and prostatic cancer. Br J Urol 1992;70:183-7.
19. Collins GN, Lee RJ, McKelvie GB, Rogers ACN, Hehir M. Relationship between prostate specific antigen, prostate volume and age in the benign prostate. Br J Urol 1993;71:445-50.
20. Benson MC, Olsson CA. Prostate specific antigen and prostate specific antigen density. Roles in patient evaluation and management. Cancer 1994;74:1667-73.
21. Benson MC, Wang IS, Pantuk A, Ring K, Kaplan SA, Cooner WH. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992; 147:815-6.
22. 1-antichymotrypsin is the major form of prostate specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51: 222-6.
23. Christenson A, Laurell CB, Lilja H. Enzymatic activity of prostate specific antigen and its reaction with extracellular serine proteinase inhibitors. Eur J Biochem 1990;194:755-63.
24. Jung K, Lein M, Schnorr D, Henke W, Brux B, Loening S. Prostate specific antigen: influence of its free and complexed form on the clinical validity as tumour marker. Lab Med 1995;19:210-7.
25. Hammerer PG, McNeal JE, Stamey TA. Correlation between prostate specific antigen levels and the volume of the individual glandular zones of the human prostate. J Urol 1995;153: 111-4.